Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Thousands of GE Ventilators Recalled Over Risk of Failure, Patient Deaths February 10, 2020 Russell Maas Add Your Comments A Class I recall has been issued for several thousand GE mechanical ventilation systems, which may contain a defect that causes the devices to stop working unexpectedly, increasing the risk of organ injury or death to patients. The FDA announced a GE Carestation 600 series anesthesia systems recall on February 7, because the cabling connection inside the device may come loose, causing the mechanical ventilation to stop working. The GE Carestation 600 series devices are used in hospitals, surgical centers and clinics to provide general inhalation anesthesia and breathing support to pediatric and adult patients. The mechanical ventilators are critical for continued breathing support and surgical procedures where patients must undergo anesthesia. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the event of a loose cable connection inside the system, loss of mechanical ventilation could occur, the recall notice warns. Patients requiring breathing support could suffer from low blood oxygen levels, resulting in tissue or organ damage, or death. GE Healthcare issued a medical device warning on November 25, 2019, indicating that in the event of a loss of power scenario, the device will emit a high priority audio and visual alarm to alert the health care provider. A message on the display screen will read “Ventilate manually”. Healthcare providers should immediately switch the device from mechanical ventilation to manual ventilation or switch to another anesthesia system, the company warned. The recall involves approximately 3,599 GE Carestation 600 series anesthesia systems with model numbers 620, 650, 650c, A1 and serial numbers 1012-9620-000, 1012-9620-002, 1012-9650-000, 1012-9650-002, 1012-9655-000, 1012-9655-002. The impacted devices were manufactured by GE Healthcare Manufacturing Co. from August 2018 through July 2019, and were distributed to hospitals surgical centers and clinics throughout the United States. The FDA has classified the recall with a Class I status, indicating it is the most serious type of recall and continued use of the device poses a reasonable probability of serious adverse health consequences or death. To date, no injuries or deaths have been reported in connection with the problem. GE Healthcare indicated customers may continue to use the devices, but a representative will contact them to schedule an inspection and correct the affected systems. Customers with additional questions or concerns regarding the recall should contact GE Healthcare Customer Service at 1-800-437-1171. The recall came just days after GE Healthcare issued another Class I recall of certain CARESCAPE Respiratory Modules on February 4, due to a manufacturing defect that may cause the devices to display incorrect oxygen values, leading to high or low blood oxygen levels in the patient. According to that recall, a defect in the design of the monitoring devices could calculate and display incorrect oxygen values, causing long-term high or low blood oxygen levels. The agency warns these incidents could result in serious adverse health consequences for patients including organ damage, tissue injury, increased chance of infection, or death. The recall included Airway Gas Option N-CAiO, and CARESCAPE Respiratory Modules with model numbers E-sCO, sCOVX, E-sCAiO, E-sCAiOV, E-sCAiOE, and E-sCAiOVE. The devices were manufactured by GE Healthcare of Chicago, Illinois from June 7, 2019 through August 16, 2019 and were distributed for sale to healthcare facilities across the United States. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: GE Healthcare, Ventilator Recall More Lawsuit Stories Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 January 23, 2026 LINX Reflux Management System Lawsuit Alleges Implant Failed, Requiring Surgical Removal January 23, 2026 Honda Class Action Lawsuit Claims Recall Did Not Fully Address Engine Defect January 23, 2026 0 Comments X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (Posted: yesterday) Lawyers involved in Depo-Provera litigation have agreed to hold the first bellwether trial over brain tumor injuries beginning on December 7, 2026. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (01/14/2026)Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026) Insole Foot Warmer Burns Often Lead to Debridement Surgery and Long-Term Nerve Damage, Lawsuits Allege (Posted: 2 days ago) Defective heated insoles and electric socks have been linked to severe foot burns that required surgical debridement, with lawsuits now alleging long-term nerve damage and mobility loss. MORE ABOUT: HEATED INSOLE LAWSUITAmazon Heated Insoles Lawsuit Alleges Foot Warmer Burst Into Flames Inside Boot (01/05/2026)Amazon Foot Warmer Lawsuit Alleges Heated Insoles Exploded, Caught Fire (12/10/2025) Ozempic Side Effects Led to Severe Vision Loss, Lawsuit Claims (Posted: 3 days ago) A recent Ozempic NAION lawsuit claims Novo Nordisk knew the drug was linked to vision loss risks for years, but failed to update the label warnings. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (01/13/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)
LINX Reflux Management System Lawsuit Alleges Implant Failed, Requiring Surgical Removal January 23, 2026
Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (Posted: yesterday) Lawyers involved in Depo-Provera litigation have agreed to hold the first bellwether trial over brain tumor injuries beginning on December 7, 2026. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (01/14/2026)Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)
Insole Foot Warmer Burns Often Lead to Debridement Surgery and Long-Term Nerve Damage, Lawsuits Allege (Posted: 2 days ago) Defective heated insoles and electric socks have been linked to severe foot burns that required surgical debridement, with lawsuits now alleging long-term nerve damage and mobility loss. MORE ABOUT: HEATED INSOLE LAWSUITAmazon Heated Insoles Lawsuit Alleges Foot Warmer Burst Into Flames Inside Boot (01/05/2026)Amazon Foot Warmer Lawsuit Alleges Heated Insoles Exploded, Caught Fire (12/10/2025)
Ozempic Side Effects Led to Severe Vision Loss, Lawsuit Claims (Posted: 3 days ago) A recent Ozempic NAION lawsuit claims Novo Nordisk knew the drug was linked to vision loss risks for years, but failed to update the label warnings. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (01/13/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)